Distribution and characteristics of Escherichia coli clonal group A

被引：64

作者：

Johnson, JR

Murray, AC

Kuskowski, MA

Schubert, S

Prère, MF

Picard, B

Colodner, R

Raz, R

机构：

[1] Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA

[2] Univ Minnesota, Minneapolis, MN USA

[3] Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany

[4] Ctr Hosp Univ Purpan, Toulouse, France

[5] Hop Morvan, Brest, France

[6] HaEmek Med Ctr, Afula, Israel

[7] Techn Sch Med, Afula, Israel

来源：

EMERGING INFECTIOUS DISEASES | 2005年 / 11卷 / 01期

关键词：

D O I：

10.3201/eid1101.040418

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Among 1,102 recent Escherichia coli clinical isolates, clonal group A was identified in 17 of 20 (U.S. and non-U.S.) geographic locales, mainly among U.S. isolates (9% vs. 3%; p < 0.001) and those resistant to trimethoprim-sulfamethoxazole (10% vs. 1.7%; p < 0.001). The extensive antimicrobial resistance and virulence profiles of clonal group A may underlie its recent widespread emergence.

引用

收藏

页码：141 / 145

页数：5

相关论文

共 15 条

[1] Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates [J].

Burman, WJ ;

Breese, PE ;

Murray, BE ;

Singh, KV ;

Batal, HA ;

MacKenzie, TD ;

Ogle, JW ;

Wilson, ML ;

Reves, RR ;

Mehler, PS .

AMERICAN JOURNAL OF MEDICINE, 2003, 115 (05) :358-364

[2] Rapid and simple determination of the Escherichia coli phylogenetic group [J].

Clermont, O ;

Bonacorsi, S ;

Bingen, E .

APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (10) :4555-4558

[3] Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction [J].

Enne, VI ;

Livermore, DM ;

Stephens, P ;

Hall, LMC .

LANCET, 2001, 357 (9265) :1325-1328

[4] Rapid and specific detection of Escherichia coli clonal group a by gene-specific PCR [J].

Johnson, JR ;

Owens, K ;

Manges, AR ;

Riley, LW .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) :2618-2622

[5] Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans [J].

Johnson, JR ;

Kuskowski, MA ;

Owens, K ;

Gajewski, A ;

Winokur, PL .

JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (05) :759-768

[6] Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products [J].

Johnson, JR ;

Murray, AC ;

Gajewski, A ;

Sullivan, M ;

Snippes, P ;

Kuskowski, MA ;

Smith, KE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2161-2168

[7] Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections [J].

Johnson, JR ;

Russo, TA .

JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (06) :859-864

[8] A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis [J].

Johnson, JR ;

Manges, AR ;

O'Bryan, TT ;

Riley, LW .

LANCET, 2002, 359 (9325) :2249-2251

[9] Clonal origin, virulence factors, and virulence [J].

Johnson, JR ;

Kuskowski, M .

INFECTION AND IMMUNITY, 2000, 68 (01) :424-425

[10] Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis [J].

Manges, AR ;

Dietrich, PS ;

Riley, LW .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :329-334